Key result
Subarachnoid hemorrhage prevents hypertension-induced blood-brain barrier disruption, resulting in 0 demonstrable lesions.
Answers are grounded in this paper and cite their sources.
In three groups of cats, the authors studied the effect of subarachnoid hemorrhage (SAH) on the permeability of the blood-brain barrier (BBB) to the penetration of Evans blue-protein complex. One group received arterial hypertension alone, one group SAH alone, and one group SAH followed by arterial hypertension. Animals subjected to arterial hypertension alone showed areas of BBB breakdown. However, when cats were rendered hypertensive after SAH, there were no demonstrable BBB lesions. The SAH was produced by intracisternal injection of whole blood and hypertension by the intravenous injection of metaraminol. The preservation of the BBB after SAH is discussed. Vasospasm is considered as a possible hemodynamic variable responsible for the protection of the BBB from hypertensive damage. The need for a new model is proposed to further investigate the state of the BBB after SAH.
No takes yet. Share an insight, caveat, or question.
Peterson et al. (1983) studied Experimental subarachnoid hemorrhage. Subarachnoid hemorrhage (intracisternal injection of whole blood) followed by arterial hypertension (intravenous metaraminol) vs. Arterial hypertension alone or subarachnoid hemorrhage alone was evaluated on Permeability of the blood-brain barrier to Evans blue-protein complex penetration. Subarachnoid hemorrhage followed by metaraminol-induced arterial hypertension in cats resulted in 0 demonstrable blood-brain barrier lesions compared to areas of breakdown with hypertension alone.
Synapse has enriched 10 related papers. Consider them for comparative context: